Systems and methods for treating a patient's mucus hypersecretion condition are disclosed herein. Certain implementations may involve a method for reducing mucus secretion in an upper airway of a patient to treat at least one of post nasal drip or chronic cough. The method may include advancing a treatment delivery portion of an energy-based treatment device into a nostril of the patient. The treatment delivery portion may contact mucosal tissue of the upper airway without piercing the mucosal tissue. The treatment delivery portion may deliver treatment to at least one tissue selected from the group of the mucosal tissue and another tissue underlying the mucosal tissue to modify a property of the at least one tissue and thus treat at least one of post nasal drip or chronic cough in the patient.

Energy delivery devices and methods that have one or more features to measure or estimate the amount of energy dose delivered to a target material. Methods and systems for calculating an energy dose to be delivered to the target material. The devices and methods deliver an accurate energy dose to the target material. Devices, systems and methods using microwave energy delivery devices can calculate the energy dose from returned power measurements. Systems and methods adjusting one or more energy delivery parameters or one or more system components while delivering an energy dose to achieve a desired thermal effect.

The present disclosure is directed to a method for treating tissue in a passageway within a body. The method may include positioning a medical device adjacent a treatment site in the passageway. The medical device may include an elongate member having a proximal end and a distal end, and an energy emitting portion positioned adjacent the distal end. The method may further include supplying an amount of energy from an energy source to the energy emitting portion. A first portion of the amount of the energy may be transmitted through the energy emitting portion to the tissue and a second portion of the amount of energy may be reflected from the energy emitting portion. The method may further include monitoring a signal corresponding to one of the first portion of the amount of energy and the second portion of the amount of energy.

Surgical tissue fusion instrument and support structure having two gripping structures which are movable relative to each other and which are designed to bring together biological tissue sections that are to be connected to each other, with heat-generating means which are assigned to the gripping structures and, during tissue fusion, cause heat to be introduced in the area of a connection site of the biological tissue sections, and also with a support structure which is held between the gripping structures and, during tissue fusion, is operatively connected to the tissue sections. The support structure has at least one additional physical functional structure for aiding or promoting the tissue fusion.

A wall of a uterus is ablated by expanding a structure in the uterus and applying energy across the wall of the structure into the uterine wall. An exterior surface of the structure conforms to an inner wall of the uterus, and the energy may cause vapor to collect between the wall and the structure. The vapor is released by providing a barrier to release which is inflated at a pressure above which the barrier at least partially collapses to allow the vapor to leave the uterus.

An energy treatment device includes a probe, a sheath unit, a fixed handle, a movable handle unit, a rotation axis, a jaw and a thickness-reduced portion. The thickness-reduced portion is one part of the jaw and is provided between the rotation axis and a distal end of the jaw. The thickness-reduced portion flexes in response to a reaction force when one part of the jaw receives the reaction force from a treatment target due to the opening and closing of the movable handle unit to the treatment target. The thickness-reduced portion prevents the deformation of the other parts of the jaw by flexing.

An electrosurgical device is disclosed. The electrosurgical device includes a handle, a shaft extending distally from the handle, and an end effector coupled to a distal end of the shaft. The end effector comprises a first electrode and a second electrode. The second electrode includes a first position and a second position. The second electrode is configured to move from the first position to the second position when a force is applied to the end effector by a tissue section. The first electrode and the second electrode define a treatment area when the second electrode is in the second position.

Devices and methods that provide minimally-invasive approaches to performing treatments on soft tissue, such as that found in the bladder using various natural access paths such as transvaginal and transurethral. Treatments include the application of energy to nerves found in, under and around the trigone region of the bladder.

A surface ablation system includes an electrosurgical generator, and elongated shaft, a plug, and a circuit assembly. The elongated shaft includes a proximal end portion and a distal end portion. The plug is supported on the distal end portion of the elongated shaft. The circuit assembly is supported on the plug and in electrical communication with the electrosurgical generator. The circuit assembly includes spaced-apart traces positioned in arrays about the plug. Each of the traces is configured to emit electrosurgical energy along the arrays to treat tissue positioned adjacent to the traces.

Devices and methods for treating rhinitis are described where the devices are configured to ablate a single nerve branch or multiple nerve branches of the posterior nasal nerves located within the nasal cavity. A surgical probe may be inserted into the sub-mucosal space of a lateral nasal wall and advanced towards a posterior nasal nerve associated with a middle nasal turbinate or an inferior nasal turbinate into a position proximate to the posterior nasal nerve where neuroablation of the posterior nasal nerve may be performed with the surgical probe. The probe device may utilize a visible light beacon that provides trans-illumination of the sub-mucosal tissue or an expandable structure disposed in the vicinity of the distal end of the probe shaft to enable the surgeon to visualize the sub-mucosal position of the distal end of the surgical probe from inside the nasal cavity using, e.g., an endoscope.